Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Healthequity Inc (NASDAQ: HQY) closed the day trading at $84.32 down -17.07% from the previous closing price of $101.67. In other words, the price has decreased by -$17.07 from its previous closing price. On the day, 6.43 million shares were traded. HQY stock price reached its highest trading level at $87.4 during the session, while it also had its lowest trading level at $80.33.
Ratios:
For a better understanding of HQY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.56. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $126.
On November 15, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $108.
On April 04, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $101.JMP Securities initiated its Mkt Outperform rating on April 04, 2024, with a $101 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 10 ’25 when SELANDER ROBERT W sold 5,750 shares for $111.29 per share. The transaction valued at 639,927 led to the insider holds 78,219 shares of the business.
ROBERT SELANDER bought 5,750 shares of HQY for $639,927 on Feb 10 ’25. On Jan 07 ’25, another insider, Elimelech Rosner, who serves as the Officer of the company, bought 1,707 shares for $97.54 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 8811018240 and an Enterprise Value of 8109288448. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 76.92, and their Forward P/E ratio for the next fiscal year is 18.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.35 while its Price-to-Book (P/B) ratio in mrq is 3.45. Its current Enterprise Value per Revenue stands at 6.759 whereas that against EBITDA is 22.198.
Stock Price History:
The Beta on a monthly basis for HQY is 0.43, which has changed by 0.02579081 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $115.59, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is -19.79%, while the 200-Day Moving Average is calculated to be -6.46%.
Shares Statistics:
Over the past 3-months, HQY traded about 781.10K shares per day on average, while over the past 10 days, HQY traded about 1525830 shares per day. A total of 86.82M shares are outstanding, with a floating share count of 84.54M. Insiders hold about 2.45% of the company’s shares, while institutions hold 104.91% stake in the company. Shares short for HQY as of 1740700800 were 4307148 with a Short Ratio of 5.51, compared to 1738281600 on 4396955. Therefore, it implies a Short% of Shares Outstanding of 4307148 and a Short% of Float of 5.81.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 9.0 analysts currently analyzing and rating the stock of Healthequity Inc (HQY).The consensus estimate for the next quarter is $0.9, with high estimates of $0.96 and low estimates of $0.84.
Analysts are recommending an EPS of between $3.7 and $3.6 for the fiscal current year, implying an average EPS of $3.66. EPS for the following year is $4.5, with 12.0 analysts recommending between $4.79 and $4.34.
Revenue Estimates
10 analysts predict $322.26M in revenue for the current quarter. It ranges from a high estimate of $327.08M to a low estimate of $309M. As of the current estimate, Healthequity Inc’s year-ago sales were $287.6MFor the next quarter, 10 analysts are estimating revenue of $320.79M. There is a high estimate of $335.73M for the next quarter, whereas the lowest estimate is $315.76M.
A total of 14 analysts have provided revenue estimates for HQY’s current fiscal year. The highest revenue estimate was $1.35B, while the lowest revenue estimate was $1.28B, resulting in an average revenue estimate of $1.3B. In the same quarter a year ago, actual revenue was $1.2BBased on 13 analysts’ estimates, the company’s revenue will be $1.44B in the next fiscal year. The high estimate is $1.51B and the low estimate is $1.4B.
